Literature DB >> 12207857

Intraductal Papillary Mucinous Neoplasm.

Suresh T. Chari1.   

Abstract

Surgical resection is the treatment of choice for intraductal papillary mucinous tumor. In intraductal papillary mucinous neoplasm, the extent of resection is determined by the extent of the disease. If, by pre- and intraoperative assessment, the disease appears localized, limited resection (pancreaticoduodenectomy or distal pancreatectomy) should be performed, ensuring that frozen sections show negative margins. Total pancreatectomy should be considered for extensive disease.

Entities:  

Year:  2002        PMID: 12207857     DOI: 10.1007/s11938-002-0022-1

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  15 in total

1.  Intraductal papillary mucinous tumors of the pancreas: thin-section helical CT findings.

Authors:  Y Fukukura; F Fujiyoshi; M Sasaki; H Inoue; S Yonezawa; M Nakajo
Journal:  AJR Am J Roentgenol       Date:  2000-02       Impact factor: 3.959

2.  Case of intraductal papillary mucinous tumor (noninvasive adenocarcinoma) of the pancreas resected 27 years after onset.

Authors:  Y Shimizu; K Yasui; T Morimoto; A Torii; K Yamao; K Ohhashi
Journal:  Int J Pancreatol       Date:  1999-10

3.  Intraductal mucin-hypersecreting neoplasms of the pancreas. A clinicopathologic study of eight patients.

Authors:  F Rickaert; M Cremer; J Devière; L Tavares; J P Lambilliotte; S Schröder; D Wurbs; G Klöppel
Journal:  Gastroenterology       Date:  1991-08       Impact factor: 22.682

4.  Intraductal papillary and mucinous tumors of the pancreas: accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long-term outcome in a large surgical series.

Authors:  C Cellier; E Cuillerier; L Palazzo; F Rickaert; J F Flejou; B Napoleon; D Van Gansbeke; N Bely; P Ponsot; C Partensky; P H Cugnenc; J P Barbier; J Devière; M Cremer
Journal:  Gastrointest Endosc       Date:  1998-01       Impact factor: 9.427

5.  Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature. Members of the Pancreas Clinic, and Pancreatic Surgeons of Mayo Clinic.

Authors:  E V Loftus; B A Olivares-Pakzad; K P Batts; M C Adkins; D H Stephens; M G Sarr; E P DiMagno
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

6.  Intraductal papillary mucinous tumours of the pancreas. Clinical and therapeutic issues in 32 patients.

Authors:  C Azar; J Van de Stadt; F Rickaert; M Devière; M Baize; G Klöppel; M Gelin; M Cremer
Journal:  Gut       Date:  1996-09       Impact factor: 23.059

7.  Mucin-hypersecreting carcinoma of the pancreas.

Authors:  Y Itai; T Kokubo; Y Atomi; A Kuroda; Y Haraguchi; A Terano
Journal:  Radiology       Date:  1987-10       Impact factor: 11.105

8.  Intraductal papillary mucinous neoplasms of the pancreas associated with so-called "mucinous ductal ectasia". Histochemical and immunohistochemical analysis of 29 cases.

Authors:  E Nagai; T Ueki; K Chijiiwa; M Tanaka; M Tsuneyoshi
Journal:  Am J Surg Pathol       Date:  1995-05       Impact factor: 6.394

9.  Exocrine pancreatic tumours and their histological classification. A study based on 167 autopsy and 97 surgical cases.

Authors:  T Morohoshi; G Held; G Klöppel
Journal:  Histopathology       Date:  1983-09       Impact factor: 5.087

10.  Mucinous ductal ectasia: cholangiopancreatographic and endoscopic findings.

Authors:  I Raijman; P Kortan; D Walden; G Kandel; N E Marcon; G B Haber
Journal:  Endoscopy       Date:  1994-03       Impact factor: 10.093

View more
  1 in total

1.  Advances in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasms, and Pancreatitis.

Authors:  Santhi Swaroop Vege; Stephen J Pandol
Journal:  Gastroenterology       Date:  2018-08-02       Impact factor: 22.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.